Nav: Home

CTCA at Western First Arizona Hospital awarded Joint Commission Lung Cancer Certification

September 28, 2015

(Goodyear, Arizona - September 28, 2015) - Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center (Western) in Goodyear, Arizona, announced that it has earned The Joint Commission's Gold Seal of Approval® for Lung Cancer Certification.

The Gold Seal of Approval® is a symbol of quality that reflects an organization's commitment to providing safe and effective patient care. CTCA® at Western is the first hospital in the Southwest and only the sixth hospital in the U.S. to receive this esteemed designation.

"Cancer Treatment Centers of America at Western Regional Medical Center has thoroughly demonstrated a high level of care for patients with lung cancer," said Wendi J. Roberts, RN, executive director, Certification Programs, The Joint Commission. "We commend CTCA at Western for becoming a leader in lung cancer care, potentially providing a higher standard of service for lung cancer patients in its community."

CTCA at Western underwent a rigorous on-site review in August. A Joint Commission expert evaluated compliance with national disease-specific care standards as well as with lung cancer-specific requirements. Clinical practice guidelines and performance measures were also assessed.

The Lung Center of Excellence at CTCA at Western is dedicated to providing state-of-the-art compassionate care to patients with lung cancer and to their families. CTCA at Western offers a multidisciplinary, interactive team approach for prevention and screening, while treating early and complex lung cancer through evidence based practice and research.

"We have consistently strived to provide the best care possible to our patients," stated Mark Kharoufeh, RN, BSN, Assistant Vice President of Oncology Patient Services, CTCA at Western. "This certification provides a third-party validation of our high-quality, consistent approach to patient care, treatment and services provided at our hospital."

Kharoufeh was the sponsor of the Lung Cancer Certification.

Physicians instrumental in the certification process also include:
  • Lanceford Chong, MD, MPH, Medical Director of Radiation Oncology, CTCA at Western
    Glen Weiss, MD, MBA, Director of Clinical Research & Medical Oncologist, CTCA at Western
    Ashish Sangal, MD, Director of Medical Education & Medical Oncologist, CTCA at Western
    Andrew Goldstein, MD, FACS, Director of Thoracic Surgery and Thoracic Surgeon, CTCA at Western
    Sharad Chandrika, MD, Pulmonologist & Intensivist at CTCA, Western

CTCA at Western adheres to the National Comprehensive Cancer Network clinical practice guidelines and has a robust clinical research program. Currently, CTCA at Western has nine active clinical trials for advanced lung cancer.

Twelve lung cancer-specific peer-reviewed manuscripts have recently been published. Additionally, CTCA at Western physicians have participated in 18 lung cancer posters and oral presentations - at both national and international conferences - including for the American Society of Clinical Oncology. Earlier this month, Dr. Weiss presented at the 16th World Conference on Lung Cancer.

Established in 2002 and awarded for a two-year period, The Joint Commission's Disease-Specific Care Certification evaluates clinical programs across the continuum of care and addresses three core areas:
  • Compliance with consensus-based national standards;
  • Effective use of evidence-based clinical practice guidelines to manage and optimize care; and
  • An organized approach to performance measurement and improvement activities.

For more information about CTCA, visit, or call (800) 615-3055.

About Cancer Treatment Centers of America®

Cancer Treatment Centers of America® (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-based complementary therapies that support patients physically and emotionally, enhancing their quality of life while reducing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit, and

The Joint Commission

Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies nearly 21,000 health care organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission at

Cancer Treatment Centers of America

Related Lung Cancer Articles:

AI helps to fight against lung cancer
Lung cancer has been the leading cause of cancer-related deaths in 2015 in United States.
Free lung-cancer screening in the Augusta area finds more than double the cancer rate of previous screenings
The first year of free lung cancer screening in the Augusta, Ga., area found more than double the rate seen in a previous large, national study as well as a Massachusetts-based screening for this No.
Antioxidants and lung cancer risk
An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect against lung cancer.
Lung cancer may go undetected in kidney cancer patients
Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C.
Hitgen and Cancer Research UK's Manchester Institute enter license agreement in lung cancer
Cancer Research UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Huntsman Cancer Institute research holds promise for personalized lung cancer treatments
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another.
High levels of estrogen in lung tissue related to lung cancer in postmenopausal women
Researchers from Kumamoto University, Japan have found that postmenopausal women with multicentric adenocarcinoma of the lung have a higher concentration of estrogen in non-cancerous areas of the peripheral lung than similar women diagnosed with single tumor lung cancer.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Pericardial window operation less efficient in cases of lung cancer than any other cancer
Pericardial window operation, a procedure, where abnormal quantity of malignant fluid, surrounding the heart, is drained into the neighbouring chest cavity, is commonly applied to patients diagnosed with cancer.

Related Lung Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".